nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Disulfiram—alcohol dependence	0.229	0.584	CbGbCtD
Rifaximin—CYP3A4—Citalopram—alcohol dependence	0.163	0.416	CbGbCtD
Rifaximin—Rifampicin—CYP2E1—alcohol dependence	0.00338	1	CrCbGaD
Rifaximin—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00332	0.122	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00297	0.11	CbGpPWpGaD
Rifaximin—Menopausal symptoms—Naltrexone—alcohol dependence	0.00274	0.00475	CcSEcCtD
Rifaximin—Migraine—Acamprosate—alcohol dependence	0.00269	0.00466	CcSEcCtD
Rifaximin—Disturbance in attention—Citalopram—alcohol dependence	0.00261	0.00452	CcSEcCtD
Rifaximin—Contusion—Citalopram—alcohol dependence	0.00259	0.00449	CcSEcCtD
Rifaximin—Pain in extremity—Naltrexone—alcohol dependence	0.00259	0.00448	CcSEcCtD
Rifaximin—Migraine—Naltrexone—alcohol dependence	0.00255	0.00441	CcSEcCtD
Rifaximin—Bone disorder—Citalopram—alcohol dependence	0.0025	0.00433	CcSEcCtD
Rifaximin—Cellulitis—Citalopram—alcohol dependence	0.00248	0.0043	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00246	0.00427	CcSEcCtD
Rifaximin—Dehydration—Naltrexone—alcohol dependence	0.00241	0.00417	CcSEcCtD
Rifaximin—Abdominal distension—Acamprosate—alcohol dependence	0.00238	0.00412	CcSEcCtD
Rifaximin—Dysphagia—Acamprosate—alcohol dependence	0.00236	0.0041	CcSEcCtD
Rifaximin—Abdominal pain upper—Naltrexone—alcohol dependence	0.00236	0.00409	CcSEcCtD
Rifaximin—Fatigue—Disulfiram—alcohol dependence	0.00235	0.00408	CcSEcCtD
Rifaximin—Pain—Disulfiram—alcohol dependence	0.00233	0.00404	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00233	0.00404	CcSEcCtD
Rifaximin—Nasopharyngitis—Naltrexone—alcohol dependence	0.00231	0.00401	CcSEcCtD
Rifaximin—Neck pain—Citalopram—alcohol dependence	0.00229	0.00396	CcSEcCtD
Rifaximin—Abnormal dreams—Citalopram—alcohol dependence	0.00223	0.00387	CcSEcCtD
Rifaximin—Influenza like illness—Citalopram—alcohol dependence	0.00219	0.0038	CcSEcCtD
Rifaximin—Pollakiuria—Acamprosate—alcohol dependence	0.00218	0.00378	CcSEcCtD
Rifaximin—Sweating increased—Naltrexone—alcohol dependence	0.00218	0.00377	CcSEcCtD
Rifaximin—Colitis—Citalopram—alcohol dependence	0.00217	0.00376	CcSEcCtD
Rifaximin—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00216	0.00374	CcSEcCtD
Rifaximin—Weight increased—Acamprosate—alcohol dependence	0.00215	0.00373	CcSEcCtD
Rifaximin—Fluid retention—Citalopram—alcohol dependence	0.00214	0.00372	CcSEcCtD
Rifaximin—Abdominal discomfort—Naltrexone—alcohol dependence	0.00214	0.00371	CcSEcCtD
Rifaximin—Weight decreased—Acamprosate—alcohol dependence	0.00214	0.00371	CcSEcCtD
Rifaximin—Hyperglycaemia—Acamprosate—alcohol dependence	0.00213	0.00369	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00212	0.0784	CbGpPWpGaD
Rifaximin—Pneumonia—Acamprosate—alcohol dependence	0.00212	0.00367	CcSEcCtD
Rifaximin—Depression—Acamprosate—alcohol dependence	0.0021	0.00364	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00208	0.0036	CcSEcCtD
Rifaximin—Urine output increased—Citalopram—alcohol dependence	0.00204	0.00354	CcSEcCtD
Rifaximin—Weight increased—Naltrexone—alcohol dependence	0.00203	0.00353	CcSEcCtD
Rifaximin—Weight decreased—Naltrexone—alcohol dependence	0.00202	0.00351	CcSEcCtD
Rifaximin—Haematuria—Acamprosate—alcohol dependence	0.00201	0.00348	CcSEcCtD
Rifaximin—Pneumonia—Naltrexone—alcohol dependence	0.00201	0.00347	CcSEcCtD
Rifaximin—Infestation—Naltrexone—alcohol dependence	0.00199	0.00345	CcSEcCtD
Rifaximin—Infestation NOS—Naltrexone—alcohol dependence	0.00199	0.00345	CcSEcCtD
Rifaximin—Depression—Naltrexone—alcohol dependence	0.00199	0.00344	CcSEcCtD
Rifaximin—Epistaxis—Acamprosate—alcohol dependence	0.00199	0.00344	CcSEcCtD
Rifaximin—Asthenia—Disulfiram—alcohol dependence	0.00196	0.00339	CcSEcCtD
Rifaximin—Ear pain—Citalopram—alcohol dependence	0.00192	0.00333	CcSEcCtD
Rifaximin—Haemoglobin—Acamprosate—alcohol dependence	0.0019	0.00329	CcSEcCtD
Rifaximin—Rhinitis—Acamprosate—alcohol dependence	0.0019	0.00329	CcSEcCtD
Rifaximin—Haemorrhage—Acamprosate—alcohol dependence	0.00189	0.00328	CcSEcCtD
Rifaximin—Hypoaesthesia—Acamprosate—alcohol dependence	0.00188	0.00326	CcSEcCtD
Rifaximin—Epistaxis—Naltrexone—alcohol dependence	0.00188	0.00326	CcSEcCtD
Rifaximin—Pharyngitis—Acamprosate—alcohol dependence	0.00188	0.00325	CcSEcCtD
Rifaximin—Polyuria—Citalopram—alcohol dependence	0.00187	0.00324	CcSEcCtD
Rifaximin—Oedema peripheral—Acamprosate—alcohol dependence	0.00186	0.00323	CcSEcCtD
Rifaximin—Dizziness—Disulfiram—alcohol dependence	0.0018	0.00313	CcSEcCtD
Rifaximin—Pharyngitis—Naltrexone—alcohol dependence	0.00178	0.00308	CcSEcCtD
Rifaximin—Tinnitus—Acamprosate—alcohol dependence	0.00176	0.00306	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00176	0.0649	CbGpPWpGaD
Rifaximin—Hot flush—Citalopram—alcohol dependence	0.00175	0.00304	CcSEcCtD
Rifaximin—Amnesia—Citalopram—alcohol dependence	0.00174	0.00302	CcSEcCtD
Rifaximin—Menopausal symptoms—Citalopram—alcohol dependence	0.00174	0.00301	CcSEcCtD
Rifaximin—Rash—Disulfiram—alcohol dependence	0.00172	0.00298	CcSEcCtD
Rifaximin—Headache—Disulfiram—alcohol dependence	0.00171	0.00296	CcSEcCtD
Rifaximin—Hypoglycaemia—Citalopram—alcohol dependence	0.00168	0.00291	CcSEcCtD
Rifaximin—Tinnitus—Naltrexone—alcohol dependence	0.00167	0.00289	CcSEcCtD
Rifaximin—Mental disorder—Acamprosate—alcohol dependence	0.00166	0.00287	CcSEcCtD
Rifaximin—Malnutrition—Acamprosate—alcohol dependence	0.00165	0.00285	CcSEcCtD
Rifaximin—Hyponatraemia—Citalopram—alcohol dependence	0.00165	0.00285	CcSEcCtD
Rifaximin—Pain in extremity—Citalopram—alcohol dependence	0.00164	0.00284	CcSEcCtD
Rifaximin—Angiopathy—Naltrexone—alcohol dependence	0.00162	0.00281	CcSEcCtD
Rifaximin—Flatulence—Acamprosate—alcohol dependence	0.00162	0.00281	CcSEcCtD
Rifaximin—Migraine—Citalopram—alcohol dependence	0.00161	0.0028	CcSEcCtD
Rifaximin—Mediastinal disorder—Naltrexone—alcohol dependence	0.00161	0.0028	CcSEcCtD
Rifaximin—Back pain—Acamprosate—alcohol dependence	0.00159	0.00276	CcSEcCtD
Rifaximin—Muscle spasms—Acamprosate—alcohol dependence	0.00158	0.00274	CcSEcCtD
Rifaximin—Mental disorder—Naltrexone—alcohol dependence	0.00157	0.00272	CcSEcCtD
Rifaximin—Malnutrition—Naltrexone—alcohol dependence	0.00156	0.0027	CcSEcCtD
Rifaximin—Tremor—Acamprosate—alcohol dependence	0.00154	0.00267	CcSEcCtD
Rifaximin—Flatulence—Naltrexone—alcohol dependence	0.00154	0.00266	CcSEcCtD
Rifaximin—Ill-defined disorder—Acamprosate—alcohol dependence	0.00153	0.00265	CcSEcCtD
Rifaximin—Dehydration—Citalopram—alcohol dependence	0.00152	0.00264	CcSEcCtD
Rifaximin—Anaemia—Acamprosate—alcohol dependence	0.00152	0.00264	CcSEcCtD
Rifaximin—Back pain—Naltrexone—alcohol dependence	0.00151	0.00261	CcSEcCtD
Rifaximin—Angioedema—Acamprosate—alcohol dependence	0.0015	0.00261	CcSEcCtD
Rifaximin—Muscle spasms—Naltrexone—alcohol dependence	0.0015	0.0026	CcSEcCtD
Rifaximin—Abdominal pain upper—Citalopram—alcohol dependence	0.0015	0.00259	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0015	0.0552	CbGpPWpGaD
Rifaximin—Malaise—Acamprosate—alcohol dependence	0.00149	0.00257	CcSEcCtD
Rifaximin—Vertigo—Acamprosate—alcohol dependence	0.00148	0.00256	CcSEcCtD
Rifaximin—Syncope—Acamprosate—alcohol dependence	0.00148	0.00256	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00148	0.00256	CcSEcCtD
Rifaximin—Nasopharyngitis—Citalopram—alcohol dependence	0.00147	0.00254	CcSEcCtD
Rifaximin—Tremor—Naltrexone—alcohol dependence	0.00146	0.00253	CcSEcCtD
Rifaximin—Loss of consciousness—Acamprosate—alcohol dependence	0.00145	0.00251	CcSEcCtD
Rifaximin—Ill-defined disorder—Naltrexone—alcohol dependence	0.00145	0.00251	CcSEcCtD
Rifaximin—Cough—Acamprosate—alcohol dependence	0.00144	0.00249	CcSEcCtD
Rifaximin—Abdominal distension—Citalopram—alcohol dependence	0.00143	0.00247	CcSEcCtD
Rifaximin—Angioedema—Naltrexone—alcohol dependence	0.00142	0.00247	CcSEcCtD
Rifaximin—Dysphagia—Citalopram—alcohol dependence	0.00142	0.00246	CcSEcCtD
Rifaximin—Malaise—Naltrexone—alcohol dependence	0.00141	0.00243	CcSEcCtD
Rifaximin—Myalgia—Acamprosate—alcohol dependence	0.0014	0.00243	CcSEcCtD
Rifaximin—Chest pain—Acamprosate—alcohol dependence	0.0014	0.00243	CcSEcCtD
Rifaximin—Arthralgia—Acamprosate—alcohol dependence	0.0014	0.00243	CcSEcCtD
Rifaximin—Syncope—Naltrexone—alcohol dependence	0.0014	0.00242	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00139	0.00241	CcSEcCtD
Rifaximin—Discomfort—Acamprosate—alcohol dependence	0.00139	0.0024	CcSEcCtD
Rifaximin—Sweating increased—Citalopram—alcohol dependence	0.00138	0.00239	CcSEcCtD
Rifaximin—Dry mouth—Acamprosate—alcohol dependence	0.00137	0.00238	CcSEcCtD
Rifaximin—Loss of consciousness—Naltrexone—alcohol dependence	0.00137	0.00237	CcSEcCtD
Rifaximin—Cough—Naltrexone—alcohol dependence	0.00136	0.00236	CcSEcCtD
Rifaximin—Abdominal discomfort—Citalopram—alcohol dependence	0.00136	0.00235	CcSEcCtD
Rifaximin—Confusional state—Acamprosate—alcohol dependence	0.00136	0.00235	CcSEcCtD
Rifaximin—Anaphylactic shock—Acamprosate—alcohol dependence	0.00134	0.00233	CcSEcCtD
Rifaximin—Infection—Acamprosate—alcohol dependence	0.00134	0.00231	CcSEcCtD
Rifaximin—Arthralgia—Naltrexone—alcohol dependence	0.00133	0.0023	CcSEcCtD
Rifaximin—Chest pain—Naltrexone—alcohol dependence	0.00133	0.0023	CcSEcCtD
Rifaximin—Myalgia—Naltrexone—alcohol dependence	0.00133	0.0023	CcSEcCtD
Rifaximin—Dysuria—Citalopram—alcohol dependence	0.00132	0.0023	CcSEcCtD
Rifaximin—Shock—Acamprosate—alcohol dependence	0.00132	0.00229	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00132	0.00228	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00132	0.00228	CcSEcCtD
Rifaximin—Discomfort—Naltrexone—alcohol dependence	0.00131	0.00227	CcSEcCtD
Rifaximin—Pollakiuria—Citalopram—alcohol dependence	0.00131	0.00227	CcSEcCtD
Rifaximin—Skin disorder—Acamprosate—alcohol dependence	0.00131	0.00226	CcSEcCtD
Rifaximin—Hyperhidrosis—Acamprosate—alcohol dependence	0.0013	0.00225	CcSEcCtD
Rifaximin—Dry mouth—Naltrexone—alcohol dependence	0.0013	0.00225	CcSEcCtD
Rifaximin—Photosensitivity reaction—Citalopram—alcohol dependence	0.00129	0.00224	CcSEcCtD
Rifaximin—Weight increased—Citalopram—alcohol dependence	0.00129	0.00223	CcSEcCtD
Rifaximin—Confusional state—Naltrexone—alcohol dependence	0.00128	0.00222	CcSEcCtD
Rifaximin—Weight decreased—Citalopram—alcohol dependence	0.00128	0.00222	CcSEcCtD
Rifaximin—Anorexia—Acamprosate—alcohol dependence	0.00128	0.00222	CcSEcCtD
Rifaximin—Hyperglycaemia—Citalopram—alcohol dependence	0.00128	0.00221	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00127	0.0469	CbGpPWpGaD
Rifaximin—Anaphylactic shock—Naltrexone—alcohol dependence	0.00127	0.0022	CcSEcCtD
Rifaximin—Pneumonia—Citalopram—alcohol dependence	0.00127	0.0022	CcSEcCtD
Rifaximin—Infection—Naltrexone—alcohol dependence	0.00126	0.00219	CcSEcCtD
Rifaximin—Infestation NOS—Citalopram—alcohol dependence	0.00126	0.00219	CcSEcCtD
Rifaximin—Infestation—Citalopram—alcohol dependence	0.00126	0.00219	CcSEcCtD
Rifaximin—Depression—Citalopram—alcohol dependence	0.00126	0.00218	CcSEcCtD
Rifaximin—Hypotension—Acamprosate—alcohol dependence	0.00126	0.00218	CcSEcCtD
Rifaximin—Shock—Naltrexone—alcohol dependence	0.00125	0.00217	CcSEcCtD
Rifaximin—Nervous system disorder—Naltrexone—alcohol dependence	0.00125	0.00216	CcSEcCtD
Rifaximin—Skin disorder—Naltrexone—alcohol dependence	0.00124	0.00214	CcSEcCtD
Rifaximin—Hyperhidrosis—Naltrexone—alcohol dependence	0.00123	0.00213	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00122	0.00212	CcSEcCtD
Rifaximin—Insomnia—Acamprosate—alcohol dependence	0.00122	0.00211	CcSEcCtD
Rifaximin—Anorexia—Naltrexone—alcohol dependence	0.00121	0.0021	CcSEcCtD
Rifaximin—Haematuria—Citalopram—alcohol dependence	0.0012	0.00209	CcSEcCtD
Rifaximin—Dyspnoea—Acamprosate—alcohol dependence	0.0012	0.00208	CcSEcCtD
Rifaximin—Epistaxis—Citalopram—alcohol dependence	0.00119	0.00206	CcSEcCtD
Rifaximin—Decreased appetite—Acamprosate—alcohol dependence	0.00117	0.00202	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00116	0.00201	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00116	0.00201	CcSEcCtD
Rifaximin—Insomnia—Naltrexone—alcohol dependence	0.00115	0.00199	CcSEcCtD
Rifaximin—Constipation—Acamprosate—alcohol dependence	0.00115	0.00199	CcSEcCtD
Rifaximin—Pain—Acamprosate—alcohol dependence	0.00115	0.00199	CcSEcCtD
Rifaximin—Haemoglobin—Citalopram—alcohol dependence	0.00114	0.00198	CcSEcCtD
Rifaximin—Rhinitis—Citalopram—alcohol dependence	0.00114	0.00197	CcSEcCtD
Rifaximin—Haemorrhage—Citalopram—alcohol dependence	0.00113	0.00197	CcSEcCtD
Rifaximin—Dyspnoea—Naltrexone—alcohol dependence	0.00113	0.00196	CcSEcCtD
Rifaximin—Hypoaesthesia—Citalopram—alcohol dependence	0.00113	0.00196	CcSEcCtD
Rifaximin—Pharyngitis—Citalopram—alcohol dependence	0.00113	0.00195	CcSEcCtD
Rifaximin—Urinary tract disorder—Citalopram—alcohol dependence	0.00112	0.00194	CcSEcCtD
Rifaximin—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00112	0.0413	CbGpPWpGaD
Rifaximin—Oedema peripheral—Citalopram—alcohol dependence	0.00112	0.00194	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00112	0.0412	CbGpPWpGaD
Rifaximin—Urethral disorder—Citalopram—alcohol dependence	0.00111	0.00193	CcSEcCtD
Rifaximin—Feeling abnormal—Acamprosate—alcohol dependence	0.00111	0.00192	CcSEcCtD
Rifaximin—Decreased appetite—Naltrexone—alcohol dependence	0.00111	0.00192	CcSEcCtD
Rifaximin—Gastrointestinal pain—Acamprosate—alcohol dependence	0.0011	0.0019	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.0011	0.0019	CcSEcCtD
Rifaximin—Fatigue—Naltrexone—alcohol dependence	0.0011	0.0019	CcSEcCtD
Rifaximin—Pain—Naltrexone—alcohol dependence	0.00109	0.00188	CcSEcCtD
Rifaximin—Constipation—Naltrexone—alcohol dependence	0.00109	0.00188	CcSEcCtD
Rifaximin—Urticaria—Acamprosate—alcohol dependence	0.00107	0.00185	CcSEcCtD
Rifaximin—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00106	0.0392	CbGpPWpGaD
Rifaximin—Abdominal pain—Acamprosate—alcohol dependence	0.00106	0.00184	CcSEcCtD
Rifaximin—Body temperature increased—Acamprosate—alcohol dependence	0.00106	0.00184	CcSEcCtD
Rifaximin—Tinnitus—Citalopram—alcohol dependence	0.00106	0.00183	CcSEcCtD
Rifaximin—Flushing—Citalopram—alcohol dependence	0.00105	0.00182	CcSEcCtD
Rifaximin—Feeling abnormal—Naltrexone—alcohol dependence	0.00105	0.00182	CcSEcCtD
Rifaximin—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00104	0.0018	CcSEcCtD
Rifaximin—Angiopathy—Citalopram—alcohol dependence	0.00103	0.00178	CcSEcCtD
Rifaximin—Mediastinal disorder—Citalopram—alcohol dependence	0.00102	0.00177	CcSEcCtD
Rifaximin—Urticaria—Naltrexone—alcohol dependence	0.00101	0.00175	CcSEcCtD
Rifaximin—Body temperature increased—Naltrexone—alcohol dependence	0.00101	0.00174	CcSEcCtD
Rifaximin—Abdominal pain—Naltrexone—alcohol dependence	0.00101	0.00174	CcSEcCtD
Rifaximin—Mental disorder—Citalopram—alcohol dependence	0.000994	0.00172	CcSEcCtD
Rifaximin—Hypersensitivity—Acamprosate—alcohol dependence	0.00099	0.00172	CcSEcCtD
Rifaximin—Malnutrition—Citalopram—alcohol dependence	0.000987	0.00171	CcSEcCtD
Rifaximin—Flatulence—Citalopram—alcohol dependence	0.000973	0.00169	CcSEcCtD
Rifaximin—Asthenia—Acamprosate—alcohol dependence	0.000964	0.00167	CcSEcCtD
Rifaximin—Back pain—Citalopram—alcohol dependence	0.000955	0.00165	CcSEcCtD
Rifaximin—Pruritus—Acamprosate—alcohol dependence	0.000951	0.00165	CcSEcCtD
Rifaximin—Muscle spasms—Citalopram—alcohol dependence	0.000949	0.00164	CcSEcCtD
Rifaximin—Hypersensitivity—Naltrexone—alcohol dependence	0.000937	0.00162	CcSEcCtD
Rifaximin—Tremor—Citalopram—alcohol dependence	0.000925	0.0016	CcSEcCtD
Rifaximin—Diarrhoea—Acamprosate—alcohol dependence	0.00092	0.00159	CcSEcCtD
Rifaximin—Ill-defined disorder—Citalopram—alcohol dependence	0.000916	0.00159	CcSEcCtD
Rifaximin—Anaemia—Citalopram—alcohol dependence	0.000912	0.00158	CcSEcCtD
Rifaximin—Asthenia—Naltrexone—alcohol dependence	0.000912	0.00158	CcSEcCtD
Rifaximin—Angioedema—Citalopram—alcohol dependence	0.000902	0.00156	CcSEcCtD
Rifaximin—Pruritus—Naltrexone—alcohol dependence	0.0009	0.00156	CcSEcCtD
Rifaximin—Malaise—Citalopram—alcohol dependence	0.00089	0.00154	CcSEcCtD
Rifaximin—Dizziness—Acamprosate—alcohol dependence	0.000889	0.00154	CcSEcCtD
Rifaximin—Vertigo—Citalopram—alcohol dependence	0.000887	0.00154	CcSEcCtD
Rifaximin—Syncope—Citalopram—alcohol dependence	0.000885	0.00153	CcSEcCtD
Rifaximin—Diarrhoea—Naltrexone—alcohol dependence	0.00087	0.00151	CcSEcCtD
Rifaximin—Loss of consciousness—Citalopram—alcohol dependence	0.000868	0.0015	CcSEcCtD
Rifaximin—Cough—Citalopram—alcohol dependence	0.000861	0.00149	CcSEcCtD
Rifaximin—Vomiting—Acamprosate—alcohol dependence	0.000855	0.00148	CcSEcCtD
Rifaximin—Rash—Acamprosate—alcohol dependence	0.000847	0.00147	CcSEcCtD
Rifaximin—Dermatitis—Acamprosate—alcohol dependence	0.000847	0.00147	CcSEcCtD
Rifaximin—Headache—Acamprosate—alcohol dependence	0.000842	0.00146	CcSEcCtD
Rifaximin—Dizziness—Naltrexone—alcohol dependence	0.000841	0.00146	CcSEcCtD
Rifaximin—Arthralgia—Citalopram—alcohol dependence	0.00084	0.00146	CcSEcCtD
Rifaximin—Chest pain—Citalopram—alcohol dependence	0.00084	0.00146	CcSEcCtD
Rifaximin—Myalgia—Citalopram—alcohol dependence	0.00084	0.00146	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000835	0.00145	CcSEcCtD
Rifaximin—Discomfort—Citalopram—alcohol dependence	0.00083	0.00144	CcSEcCtD
Rifaximin—Dry mouth—Citalopram—alcohol dependence	0.000822	0.00142	CcSEcCtD
Rifaximin—Confusional state—Citalopram—alcohol dependence	0.000812	0.00141	CcSEcCtD
Rifaximin—Vomiting—Naltrexone—alcohol dependence	0.000808	0.0014	CcSEcCtD
Rifaximin—Anaphylactic shock—Citalopram—alcohol dependence	0.000806	0.0014	CcSEcCtD
Rifaximin—Rash—Naltrexone—alcohol dependence	0.000802	0.00139	CcSEcCtD
Rifaximin—Dermatitis—Naltrexone—alcohol dependence	0.000801	0.00139	CcSEcCtD
Rifaximin—Infection—Citalopram—alcohol dependence	0.0008	0.00139	CcSEcCtD
Rifaximin—Nausea—Acamprosate—alcohol dependence	0.000798	0.00138	CcSEcCtD
Rifaximin—Headache—Naltrexone—alcohol dependence	0.000797	0.00138	CcSEcCtD
Rifaximin—Shock—Citalopram—alcohol dependence	0.000793	0.00137	CcSEcCtD
Rifaximin—Nervous system disorder—Citalopram—alcohol dependence	0.00079	0.00137	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000786	0.029	CbGpPWpGaD
Rifaximin—Skin disorder—Citalopram—alcohol dependence	0.000783	0.00136	CcSEcCtD
Rifaximin—Hyperhidrosis—Citalopram—alcohol dependence	0.000779	0.00135	CcSEcCtD
Rifaximin—Anorexia—Citalopram—alcohol dependence	0.000768	0.00133	CcSEcCtD
Rifaximin—Nausea—Naltrexone—alcohol dependence	0.000755	0.00131	CcSEcCtD
Rifaximin—Hypotension—Citalopram—alcohol dependence	0.000753	0.0013	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000734	0.00127	CcSEcCtD
Rifaximin—Insomnia—Citalopram—alcohol dependence	0.000729	0.00126	CcSEcCtD
Rifaximin—Dyspnoea—Citalopram—alcohol dependence	0.000718	0.00124	CcSEcCtD
Rifaximin—Decreased appetite—Citalopram—alcohol dependence	0.0007	0.00121	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000696	0.00121	CcSEcCtD
Rifaximin—Fatigue—Citalopram—alcohol dependence	0.000695	0.0012	CcSEcCtD
Rifaximin—Pain—Citalopram—alcohol dependence	0.000689	0.00119	CcSEcCtD
Rifaximin—Constipation—Citalopram—alcohol dependence	0.000689	0.00119	CcSEcCtD
Rifaximin—Feeling abnormal—Citalopram—alcohol dependence	0.000664	0.00115	CcSEcCtD
Rifaximin—Gastrointestinal pain—Citalopram—alcohol dependence	0.000659	0.00114	CcSEcCtD
Rifaximin—Urticaria—Citalopram—alcohol dependence	0.00064	0.00111	CcSEcCtD
Rifaximin—Abdominal pain—Citalopram—alcohol dependence	0.000637	0.0011	CcSEcCtD
Rifaximin—Body temperature increased—Citalopram—alcohol dependence	0.000637	0.0011	CcSEcCtD
Rifaximin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000629	0.0232	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000598	0.0221	CbGpPWpGaD
Rifaximin—Hypersensitivity—Citalopram—alcohol dependence	0.000594	0.00103	CcSEcCtD
Rifaximin—Asthenia—Citalopram—alcohol dependence	0.000578	0.001	CcSEcCtD
Rifaximin—Pruritus—Citalopram—alcohol dependence	0.00057	0.000988	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—CCAR1—alcohol dependence	0.000562	0.0207	CbGpPWpGaD
Rifaximin—Diarrhoea—Citalopram—alcohol dependence	0.000551	0.000955	CcSEcCtD
Rifaximin—Dizziness—Citalopram—alcohol dependence	0.000533	0.000923	CcSEcCtD
Rifaximin—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000526	0.0194	CbGpPWpGaD
Rifaximin—Vomiting—Citalopram—alcohol dependence	0.000512	0.000888	CcSEcCtD
Rifaximin—Rash—Citalopram—alcohol dependence	0.000508	0.00088	CcSEcCtD
Rifaximin—Dermatitis—Citalopram—alcohol dependence	0.000508	0.000879	CcSEcCtD
Rifaximin—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000506	0.0187	CbGpPWpGaD
Rifaximin—Headache—Citalopram—alcohol dependence	0.000505	0.000875	CcSEcCtD
Rifaximin—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000503	0.0186	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000496	0.0183	CbGpPWpGaD
Rifaximin—Nausea—Citalopram—alcohol dependence	0.000479	0.000829	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000422	0.0155	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000397	0.0147	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000358	0.0132	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000344	0.0127	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000338	0.0125	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000318	0.0117	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000314	0.0116	CbGpPWpGaD
Rifaximin—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00027	0.00996	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000263	0.00971	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00026	0.0096	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000224	0.00826	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000221	0.00817	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000218	0.00805	CbGpPWpGaD
Rifaximin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000215	0.00795	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.00019	0.00702	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000183	0.00673	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000177	0.00653	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000167	0.00616	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000146	0.00537	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000138	0.0051	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000118	0.00434	CbGpPWpGaD
Rifaximin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000117	0.00431	CbGpPWpGaD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	9.48e-05	0.0035	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	9.4e-05	0.00347	CbGpPWpGaD
Rifaximin—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	9.27e-05	0.00342	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—GGT1—alcohol dependence	8.63e-05	0.00318	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—MAOA—alcohol dependence	7.74e-05	0.00285	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH6—alcohol dependence	5.44e-05	0.002	CbGpPWpGaD
Rifaximin—CYP3A4—Biological oxidations—POMC—alcohol dependence	5.04e-05	0.00186	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH1A—alcohol dependence	4.5e-05	0.00166	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH4—alcohol dependence	3.83e-05	0.00141	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH7—alcohol dependence	3.26e-05	0.0012	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GGT2—alcohol dependence	3.12e-05	0.00115	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.86e-05	0.00105	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MAOB—alcohol dependence	2.37e-05	0.000872	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.01e-05	0.000742	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT2—alcohol dependence	1.71e-05	0.000631	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.61e-05	0.000593	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GGT1—alcohol dependence	1.48e-05	0.000544	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—GOT1—alcohol dependence	1.48e-05	0.000544	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—MAOA—alcohol dependence	1.32e-05	0.000488	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—POMC—alcohol dependence	8.61e-06	0.000318	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—EP300—alcohol dependence	5.71e-06	0.000211	CbGpPWpGaD
